Katie Lloyd
0000-0002-2325-8050
University of Chester
10 papers found
Refreshing results…
Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes
Netazepide inhibits pregnancy-associated plasma protein-A2 expression in type-1 gastric neuroendocrine tumors
Using systems medicine to identify a therapeutic agent with potential for repurposing in inflammatory bowel disease
Assessing the impact of exposure to permitted emulsifiers on bowel and metabolic health – introducing the FADiets study
Netazepide, a gastrin/CCK2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis
Impact of NF-κB subunit deletion on the small intestinal epithelial transcriptome following lipopolysaccharide treatment of C57BL/6 mice.
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1
Gastrin Increases miR-222 Expression in AGSGR Cells In Vitro and in the Stomachs of Hypergastrinemic INS-GAS Mice and Humans In Vivo via Activation of the CCK2 Receptor.
OC-018 Gastrin Increases Mir-222 Expression In Gastric Epithelial Cellsin VitroAnd Hypergastrinaemic Ins-gas Mice In Vivo
A scientific review: Mechanisms of valproate-mediated teratogenesis
Missing publications? Search for publications with a matching author name.